Castle Creek Pharmaceutical Holdings to Acquire Fibrocell

    NEXT STORY
    SpringWorks Therapeutics Announces Pricing Of Initial Public Offering
    PREV STORY
    Ascendis Pharma A/S Announces Presentations on Achondroplasia and TransCon™ CNP at International Skeletal Dysplasia Society Meeting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Equillium Announces Initiation of the EQUALISE Phase 1b Clinical Trial of Itolizumab for Patients with Lupus Nephritis and Provides Business Update

    author_avatar
    NASDAQ Market News

    Argos Therapeutics to Participate in SITC 2016 Annual Meeting

    DURHAM, N.C., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an ...

    author_avatar
    NASDAQ Market News

    Aduro Biotech to Present at ROTH Conference

    BERKELEY, Calif., March 07, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced ...

    author_avatar
    NASDAQ Market News